Home › Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors
 

Keywords :   


Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors

2015-10-21 21:10:12| Biotech - Topix.net

Johnson & Johnson, showing it's awareness from a shareholder sentiment standpoint, has approved a $10 billion share buyback program to reward patient and smart investors. I think if you can trust any company currently trading to navigate tough waters while also justifying investor patience and trust it's this one.

Tags: analysis deep johnson patient

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Tropical Depression Thirteen-E Graphics
02.11Summary for Tropical Depression Thirteen-E (EP3/EP132024)
02.11Fragrancing Spaces with Atmos, A Smart Home Diffuser
02.11Eastern North Pacific Tropical Weather Outlook
02.11Atlantic Tropical Weather Outlook
01.11Tropical Depression Thirteen-E Forecast Discussion Number 1
More »